NEW: Our meta-analysis of observational studies shows that statins significantly reduce the risk of HCC risk in patients with MASLD. The lipophilicity and higher cDDD of statins correlate with greater HCC risk reduction.
Full paper:
www.wjgnet.com/2220-315x/fu...
#LiverSKY #MASLD #HCC #Statins